Peter Attia and Saum Sutaria discuss the complexities, financial flows, and administrative burdens of the United States healthcare system.
View show notes here: bit.ly/3ZuHkO2
Become a member to receive exclusive content: peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: peterattiamd.com/newsletter/
Dr. Saum Sutaria is the Chairman & CEO of Tenet Healthcare & a former leader in McKinsey & Company’s Healthcare & Private Equity Practices, where he spent almost two decades shaping the field. In this episode, Saum unpacks the complexities of the U.S. healthcare system, providing a detailed overview of its structure, financial flows, & historical evolution. They delve into topics such as private insurance, Medicare, Medicaid, employer-sponsored coverage, drug pricing, PBMs & the administrative burdens impacting the system. Saum’s insights help connect healthcare spending to broader economic issues while exploring potential reforms & the role of technology in improving efficiency. Saum highlights how choice & innovation distinguish the U.S. healthcare system, explores the reasons behind exorbitant drug prices, & examines the potential solutions, challenges, & trade-offs involved in lowering costs while striving to improve access, quality, & affordability. The opinions expressed by Saum in this episode are his own & do not represent the views of his employer.
We discuss
-US healthcare system: financial scale & unique challenges
-How the US healthcare system works
-Huge growth & price impact after transition from out-of-pocket payments to the modern 3rd party payer model
-US healthcare system vs other developed nations
-Medicare & Medicaid overview
-Why the US kept a employer-sponsored insurance system rather than pursue universal healthcare
-Evolution of insurance: from catastrophic coverage to chronic disease management
-Challenge of managing healthcare costs while expanding access & demand for chronic illness care
-Balancing cost, choice, & access: US healthcare system vs Canada
-US role in pharmaceutical innovation, impact on drug pricing, & the potential effects of price controls on innovation & healthcare costs
-How misaligned incentives have driven up drug prices in the US
-Cost of innovation & choice, & sustainability of the current healthcare expenditures in the face of a shrinking workforce & aging population
-Why life expectancy is lower in the US despite excelling at extending lifespan beyond 70
-Potential solutions/challenges of controlling drugs costs
-Balancing GLP-1 drug innovation with affordability & healthcare spending sustainability
-Reducing healthcare spending: complexities, trade offs, & implications of cuts to healthcare expenditures
-Government regulation
-Hospital billing: complexity & paths to simplification
-How prioritizing access & choice increased expenditures: healthcare exchanges & the ACA
-Feasibility of a universal Medicare program
-Challenge of long-term
Why it's here
2 people recommend this, 1 disputes it
What people say. Recommended as a detailed and nuanced primer on the economics and structure of the US healthcare system.
e
epistasisin Hacker News • Recommends
On “'Profit-Enhancing Middlemen' Fuel $200B Health-Care Chaos”
…ivate insurance pays for a lot of Medicare, because Medicare reimbursement rates do not cover the costs of Medicare patients in many parts of the country. One of the better sources of information I have seen on this is actually a YouTube video, something I don't normally recommend, but getting a wholistic viewpoint is somewhat difficult otherwise: link to this video We could increase the medicare contribution cap (samething like only the first $175k of income has medicare tax applied to it), but I'm not sure that's going to fill the massive gap. Perhaps increasing the rate would also work. There could be some good things about this process, I just want to bring up that it's not a magic bullet because w…
On “Food, housing, & health care costs are a source of major stress for many people”
…es or kept them at the same level. We have chosen this to have high access, high quality care, while also choosing to reduce health with the way we subsidize our food system and force indolent lifestyle with car-dependent urban planning. The best primer on the choices that make our healthcare expensive, and where the money goes, are in this video: link to this video Unfortunately our national discussion of health care is not centered on the reality of the discussion, and is several levels of technical depth too shallow for us to have a public discussion that could reduce costs without reducing the care level for many peopl.…
On “US commercial insurers pay 254% of Medicare for the same hospital procedures”
There's a super long episode on The Drive going deep into the mechanics and economics of the US healthcare system, could be a useful addition to the conversation here: link to this video
On “Insurers rely on doctors whose judgments have been criticized by courts”
> For anyone looking for a nuanced perspective on this, I highly recommend Peter Attia's interview with Saum Sutaria (McKinsey's formed healthcare lead) The taste I got of it (introduction bit) link to this video A definition of insurance that doesn't seem to understand how randomness can be upon the group instead of the individual. A person in his situation can't be so grossly misunderstanding pooling risk over a population. I've skipped here and there among the multiple videos to get a better feeling of the whole interview, but to be blunt that perfectly fit into the stereotype of a guy coming from McKinsey.
